Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2488.3000
27.10
(
1.10
%)
NSE
Jul 14, 2026
15:31 PM
New 52W High in past week
Volume:
492.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
06 Aug 2025
2488.30
1.10%
Result Update:Gland Pharma
Hold:
Gland Pharma Ltd.
by
Axis Direct
Target: 1950 | Target met
Target
Axis Direct
We maintain our HOLD rating on the stock with a target price of Rs 1,950/share.
Gland Pharma has gained
31.68%
in the last 1 Year
More from Gland Pharma Ltd.
Recommended
Five stocks to buy from analysts this week - July 14, 2026
The Baseline |
14 Jul 2026, 04:56PM
Market closes lower amid renewed West Asia tensions
Trendlyne Marketwatch |
14 Jul 2026, 04:02PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020